CD spectroscopy is an established and valuable technique for examining protein structure, dynamics and folding. Because of its ability to sensitively detect conformational changes, it has important potential for drug discovery, enabling screening for ligand and drug binding, and detection of potential candidates for new pharmaceuticals. The binding of the anti-tumour agent Taxol to the anti-apoptosis protein Bcl-2 [Rodi, Janes, Sanganee, Holton, Wallace and Makowski (1999) J. Mol. Biol. 285, 197–204] and the binding of the anti-epileptic drug lamotrigine to voltage-gated sodium channels [Cronin, O'Reilly, Duclohier and Wallace (2003) J. Biol. Chem. 278, 10675–10682] are used as examples to show changes detectable by CD involving secondary structure, and are contrasted with the binding of the agonist carbamylcholine to acetylcholine receptors [Mielke and Wallace (1988) J. Biol. Chem. 263, 8177–8182], an example where binding does not involve a secondary structural change. Synchrotron radiation CD spectroscopy offers significant enhancements with respect to conventional CD spectroscopy, which will enable its usage for high-throughput screening and as a tool in ‘chemical genomics’ or ‘reverse chemical genetics’ strategies for ligand identification. The lower wavelength data available enable more detailed, sensitive and accurate detection, the higher light intensity permits much smaller amounts of both proteins and drug candidates to be used in the screening, and future technological developments in sample handling and detection should enable automated high-throughput screening to be performed.
Skip Nav Destination
Article navigation
Conference Article|
June 01 2003
Circular dichroism and synchrotron radiation circular dichroism spectroscopy: tools for drug discovery
B.A. Wallace;
B.A. Wallace
1
*Department of Crystallography, Birkbeck College, University of London, Malet Street, London WC1E 7HX, U.K.
1To whom correspondence should be addressed (e-mail ubcg25a@mail.cryst.bbk.ac.uk).
Search for other works by this author on:
Robert W. Janes
Robert W. Janes
†School of Biological Sciences, Queen Mary, University of London, Mile End Road, London E1 4NS, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2003 Biochemical Society
2003
Biochem Soc Trans (2003) 31 (3): 631–633.
Connected Content
A correction has been published:
Circular dichroism and synchrotron radiation circular dichroism spectroscopy: tools for drug discovery
Citation
B.A. Wallace, Robert W. Janes; Circular dichroism and synchrotron radiation circular dichroism spectroscopy: tools for drug discovery. Biochem Soc Trans 1 June 2003; 31 (3): 631–633. doi: https://doi.org/10.1042/bst0310631
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.